RxDoctor Payments Data

Erica Mitchell

Family · Augusta, GANPI 1730699737

Payments from drug & device makers

$5,149in general payments, 2019–2025

Across 199 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$863
  • Actelion Pharmaceuticals US, Inc.$538
  • AstraZeneca$537
  • Novartis$476
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$400
  • Lexicon Pharmaceuticals, Inc.$273
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,04798%
  • Education$1012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,149 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OpsumitMacitentan13$160,210
AdempasRiociguat13$158,255
EliquisApixaban100$88,572
EntrestoSacubitril/Valsartan36$28,330
JardianceEmpagliflozin17$26,096
VascepaIcosapent Ethyl21$9,176
Ranolazine ErRanolazine17$2,056
Rosuvastatin Calcium89$912
Metoprolol Succinate60$823
Diltiazem 24hr Er (Cd)Diltiazem Hcl29$666
Bisoprolol Fumarate19$630
Carvedilol50$529
Atorvastatin Calcium62$508
Telmisartan14$467
ClopidogrelClopidogrel Bisulfate34$430

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Actelion Pharmaceuticals US, Inc.Opsumit$538$160,21013 claims
BayerAdempas$142$158,25513 claims
PfizerEliquis$124$88,572100 claims
NovartisEntresto$476$28,33036 claims
Boehringer IngelheimJardiance$863$26,09617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →